Callan Family Office »

Prime Medicine shares owned by Callan Family Office

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $39k 11k 3.47

More positions owned by Callan Family Office

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Scottsdale Fds Vng Rus3000idx (VTHR)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Ishares Tr Rus 1000 Grw Etf (IWF)
Visa Com Cl A (V)

View all positions for Callan Family Office

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
ARK Investment Management
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
Geode Capital Management
UBS Group
D. E. Shaw & Co

View all funds holding Prime Medicine